RELIANCE LIFESCIENCE VIRTUAL IN PROCESS JOB RECRUITMENT FOR MULTIPLE POSITION IN MANUFACTURING DEPARTMENTS.

 RELIANCE LIFESCIENCE VIRTUAL / IN PROCESS JOB RECRUITMENT FOR B. PHARM / BSC / MSC / B.E / B.TECH / M.E / M.TECH CANDIDATES FOR MULTIPLE POSITION IN MANUFACTURING DEPARTMENTS. 

ABOUT RELIANCE LIFESCIENCE:

Reliance Life Sciences is a research-driven organization developing business opportunities in bio-therapeutics (plasma proteins, biosimilars and novel proteins), pharmaceuticals (later-generation, oncology generics), clinical research services, regenerative medicine (stem cells therapies) and molecular medicine. Reliance Life Sciences is part of the Promoter Group of Reliance Industries Limited. Reliance Institute of Life Sciences is a not-for-profit organisation, focusing on competency development in biotechnology, not only for Reliance Life Sciences, but also for the industry. The institute offers a wide range of competency development programs and diploma programs in Biotherapeutics and Clinical Research. Reliance Life Sciences operates state-of-the-art facilities in the life sciences domain. The flagship facility is the Dhirubhai Ambani Life Sciences Centre (DALC) in Navi Mumbai, India. Spread over 20 acres, DALC is among the most diverse and integrated life sciences campuses in the world, housing world-scale and world-class manufacturing facilities approved by Indian and international regulatory agencies.

JOB DETAILS:

Invites to a Virtual / In-Person Recruitment Drive for Multiple Manufacturing Positions,

DEPARTMENT: Manufacturing

QUALIFICATION: M.Sc, B.Sc, B.Pharm, B.E, B.Tech, M.E, M.Tech in Biotechnology / Biochemistry / Microbiology / Industrial Microbiology / Life Sciences

EXPERIENCE: 1 to 6 Yrs.

AREA OF EXPERTISE: Manufacturing Biosimilars / Plasma Proteins / Pharmaceuticals. 

HOW TO APPLY:

Interested candidates may send their resume to rcareers@ril.com / mukul5.sharma@ril.com.

INTAS PHARMACEUTICAL WALK IN INTERVIEW FOR B. PHARM / M. PHARM / BSC / MSC FOR REGULATORY AFFAIRS ON 19TH JULY 2022.